• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高水平的凝血因子IX会增加静脉血栓形成的风险。

High levels of factor IX increase the risk of venous thrombosis.

作者信息

van Hylckama Vlieg A, van der Linden I K, Bertina R M, Rosendaal F R

机构信息

Department of Clinical Epidemiology and Hemostasis and Thrombosis Research Center, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Blood. 2000 Jun 15;95(12):3678-82.

PMID:10845896
Abstract

Elevated plasma levels of factor VIII (> 150 IU/dL) are an important risk factor for deep vein thrombosis (DVT). Factor VIII is the cofactor of factor IXa in the activation of factor X. The risk of thrombosis in individuals with an elevated factor IX level is unknown. This study investigated the role of elevated factor IX levels in the development of DVT. We compared 426 patients with a first objectively diagnosed episode of DVT with 473 population controls. This study was part of a large population-based case-control study on risk factors for venous thrombosis, the Leiden Thrombophilia Study (LETS). Using the 90th percentile measured in control subjects (P(90) = 129 U/dL) as a cutoff point for factor IX levels, we found a 2- to 3-fold increased risk for individuals who have factor IX levels above 129 U/dL compared with individuals having factor IX levels below this cutoff point. This risk was not affected by adjustment for possible confounders (age, sex, oral contraceptive use, and high levels of factor VIII, XI, and vitamin K-dependent proteins). After exclusion of individuals with known genetic disorders, we still found an odds ratio (OR) of 2.5 (95% confidence interval [CI]: 1.6-3.9). The risk was higher in women (OR: 2.6, CI: 1.6-4.3) than in men (OR: 1.9, CI: 1.0-3.6) and appeared highest in the group of premenopausal women not using oral contraceptives (OR: 12.4, CI: 3.3-47.2). These results show that an elevated level of factor IX is a common risk factor for DVT. (Blood. 2000;95:3678-3682)

摘要

血浆中凝血因子VIII水平升高(>150 IU/dL)是深静脉血栓形成(DVT)的重要危险因素。凝血因子VIII是激活因子X过程中因子IXa的辅因子。凝血因子IX水平升高的个体发生血栓形成的风险尚不清楚。本研究调查了凝血因子IX水平升高在DVT发生中的作用。我们将426例首次经客观诊断为DVT发作的患者与473名人群对照进行了比较。本研究是一项基于人群的大型静脉血栓形成危险因素病例对照研究——莱顿血栓形成倾向研究(LETS)的一部分。以对照组中测得的第90百分位数(P(90)=129 U/dL)作为凝血因子IX水平的截断点,我们发现凝血因子IX水平高于129 U/dL的个体与低于该截断点的个体相比,风险增加了2至3倍。该风险不受对可能混杂因素(年龄、性别、口服避孕药使用情况以及凝血因子VIII、XI和维生素K依赖蛋白水平升高)进行校正的影响。在排除已知遗传性疾病的个体后,我们仍发现比值比(OR)为2.5(95%置信区间[CI]:1.6 - 3.9)。女性的风险(OR:2.6,CI:1.6 - 4.3)高于男性(OR:1.9,CI:1.0 - 3.6),且在未使用口服避孕药的绝经前女性组中似乎最高(OR:12.4,CI:3.3 - 47.2)。这些结果表明,凝血因子IX水平升高是DVT的常见危险因素。(《血液》。2000年;95:3678 - 3682)

相似文献

1
High levels of factor IX increase the risk of venous thrombosis.高水平的凝血因子IX会增加静脉血栓形成的风险。
Blood. 2000 Jun 15;95(12):3678-82.
2
Factor X levels, polymorphisms in the promoter region of factor X, and the risk of venous thrombosis.凝血因子X水平、凝血因子X启动子区域的多态性与静脉血栓形成风险
Thromb Haemost. 2001 Jun;85(6):1011-7.
3
Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis.凝血酶激活的纤维蛋白溶解抑制剂与深静脉血栓形成风险
Blood. 2000 May 1;95(9):2855-9.
4
Venous thrombosis, oral contraceptives and high factor VIII levels.静脉血栓形成、口服避孕药与高凝血因子VIII水平
Thromb Haemost. 1999 Sep;82(3):1024-7.
5
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.肥胖:静脉血栓形成风险以及与凝血因子水平和口服避孕药使用之间的相互作用。
Thromb Haemost. 2003 Mar;89(3):493-8.
6
D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.D-二聚体作为深静脉血栓形成的危险因素:莱顿血栓形成倾向研究。
Thromb Haemost. 2002 Jan;87(1):47-51.
7
Procoagulant factor levels and risk of venous thrombosis in the elderly.老年人促凝血因子水平与静脉血栓形成风险
J Thromb Haemost. 2021 Jan;19(1):186-193. doi: 10.1111/jth.15127. Epub 2020 Dec 22.
8
Differential haemostatic risk factors for pregnancy-related deep-vein thrombosis and pulmonary embolism: a population-based case-control study.妊娠相关深静脉血栓形成和肺栓塞的止血风险因素差异:基于人群的病例对照研究。
Thromb Haemost. 2012 Dec;108(6):1165-71. doi: 10.1160/TH12-05-0350. Epub 2012 Sep 26.
9
High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism.高血浆水平的凝血因子VIII:孤立性肺栓塞的一个重要危险因素。
Respirology. 2006 Jan;11(1):70-4. doi: 10.1111/j.1440-1843.2006.00786.x.
10
Elevated plasma factor VIII levels in a mixed patient population on anticoagulation and past venous thrombosis.在接受抗凝治疗和有过静脉血栓病史的混合患者人群中,血浆因子 VIII 水平升高。
J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1119-1127. doi: 10.1016/j.jvsv.2020.12.071. Epub 2020 Dec 16.

引用本文的文献

1
Plasma -Glycan Signatures Are Associated With a First Event of Venous Thromboembolism.血浆聚糖特征与静脉血栓栓塞的首次发作相关。
Arterioscler Thromb Vasc Biol. 2025 Sep;45(9):1693-1703. doi: 10.1161/ATVBAHA.125.323205. Epub 2025 Aug 7.
2
Factor IX and incident hypertension in Black and White adults: the REasons for Geographic and Racial Differences in Stroke cohort.黑人和白人成年人中的凝血因子IX与高血压发病:中风队列中地理和种族差异的原因
J Hypertens. 2025 Aug 1;43(8):1373-1380. doi: 10.1097/HJH.0000000000004045. Epub 2025 May 14.
3
Risk of First Venous Thrombosis by Comparing Different Thrombin Generation Assay Conditions: Results from the MEGA Case-control Study.
通过比较不同凝血酶生成检测条件评估首次静脉血栓形成风险:MEGA病例对照研究结果
TH Open. 2025 Mar 19;9:a25346123. doi: 10.1055/a-2534-6123. eCollection 2025.
4
Effect of Breastfeeding Duration on Coagulation in Women With and Without History of Gestational Diabetes Mellitus.母乳喂养持续时间对有和无妊娠期糖尿病病史女性凝血功能的影响。
J Clin Endocrinol Metab. 2024 Sep 16;109(10):2571-2578. doi: 10.1210/clinem/dgae172.
5
A novel factor IXa-specific enzyme-linked immunosorbent assay detects factor IXa in human plasma.一种新型的针对凝血因子IXa的酶联免疫吸附测定法可检测人血浆中的凝血因子IXa。
Res Pract Thromb Haemost. 2024 Feb 5;8(1):102338. doi: 10.1016/j.rpth.2024.102338. eCollection 2024 Jan.
6
Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential.静脉血栓栓塞相关基因变异、凝血因子水平与凝血酶生成潜能之间的关联。
EJHaem. 2024 Feb 18;5(1):47-54. doi: 10.1002/jha2.863. eCollection 2024 Feb.
7
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene.一项关于伴有因子IX基因重复的复发性危及生命的血栓形成的研究。
Thromb J. 2024 Jan 2;22(1):1. doi: 10.1186/s12959-023-00570-8.
8
Complete F9 Gene Deletion, Duplication, and Triplication Rearrangements: Implications for Factor IX Expression and Clinical Phenotypes.完整的 F9 基因缺失、重复和三重复排列:对因子 IX 表达和临床表型的影响。
Thromb Haemost. 2024 Apr;124(4):374-385. doi: 10.1055/a-2217-9837. Epub 2023 Nov 27.
9
Coagulation factors II, V, VII, IX, X and XI and mortality - a cohort study.凝血因子II、V、VII、IX、X和XI与死亡率——一项队列研究
Res Pract Thromb Haemost. 2023 Aug 30;7(6):102193. doi: 10.1016/j.rpth.2023.102193. eCollection 2023 Aug.
10
THE JEREMIAH METZGER LECTURE: TURNING GENES INTO MEDICINES: HIGHLIGHTS AND HURDLES IN THE DEVELOPMENT OF GENE THERAPY FOR GENETIC DISEASE.杰里迈亚·梅茨格讲座:将基因转化为药物:基因治疗遗传性疾病的亮点和障碍。
Trans Am Clin Climatol Assoc. 2023;133:204-233.